Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Eur J Surg Oncol

Retrieve available abstracts of 74 articles:
HTML format
Text format



Single Articles


    May 2018
  1. ORECCHIA R
    Radiation therapy for inflammatory breast cancer.
    Eur J Surg Oncol. 2018 May 17. pii: S0748-7983(18)31069.
    PubMed     Text format     Abstract available


  2. PAPALOUKA V, Gilbert FJ
    Inflammatory breast cancer-importance of breast imaging.
    Eur J Surg Oncol. 2018 May 16. pii: S0748-7983(18)31058.
    PubMed     Text format    


  3. FENTIMAN IS
    Unmet needs of men with breast cancer.
    Eur J Surg Oncol. 2018 May 15. pii: S0748-7983(18)31054.
    PubMed     Text format     Abstract available


  4. KARAKATSANIS A, Obondo C, Abdsaleh S, Hersi AF, et al
    Optimisation of breast MRI compatibility after sentinel node biopsy with paramagnetic tracers.
    Eur J Surg Oncol. 2018;44:731-732.
    PubMed     Text format    


    April 2018
  5. CSERNI G, Charafe-Jauffret E, van Diest PJ
    Inflammatory breast cancer: The pathologists' perspective.
    Eur J Surg Oncol. 2018 Apr 18. pii: S0748-7983(18)30998.
    PubMed     Text format     Abstract available


  6. WICKBERG A, Liljegren G, Killander F, Lindman H, et al
    Omitting radiotherapy in women >/= 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
    Eur J Surg Oncol. 2018 Apr 13. pii: S0748-7983(18)31007.
    PubMed     Text format     Abstract available


  7. LIM GH, Upadhyaya VS, Acosta HA, Lim JMA, et al
    Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result.
    Eur J Surg Oncol. 2018 Apr 12. pii: S0748-7983(18)31008.
    PubMed     Text format     Abstract available


  8. ARISTEI C, Kaidar-Person O, Tagliaferri L, Arenas M, et al
    The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction: The ATTM-SMART report.
    Eur J Surg Oncol. 2018;44:436-443.
    PubMed     Text format     Abstract available


  9. MAXWELL AJ, Clements K, Hilton B, Dodwell DJ, et al
    Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.
    Eur J Surg Oncol. 2018;44:429-435.
    PubMed     Text format     Abstract available


  10. KUERER HM
    Navigating treatment controversies for DCIS in the era of genomic profiling and active surveillance trials.
    Eur J Surg Oncol. 2018;44:386-387.
    PubMed     Text format    


  11. LAYEEQUR RAHMAN R, Marshall AJ
    Evidence basis for sentinel node biopsy post neoadjuvant chemotherapy - Bias is a 4-letter word.
    Eur J Surg Oncol. 2018;44:541-542.
    PubMed     Text format    


    March 2018
  12. VICINI E, Invento A, Cuoghi M, Bafile A, et al
    Neoadjuvant systemic treatment for breast cancer in Italy: The Italian Society of Surgical Oncology (SICO) Breast Oncoteam survey.
    Eur J Surg Oncol. 2018 Mar 31. pii: S0748-7983(18)30987.
    PubMed     Text format     Abstract available


  13. LAGENDIJK M, van Egdom LSE, Richel C, van Leeuwen N, et al
    Patient reported outcome measures in breast cancer patients.
    Eur J Surg Oncol. 2018 Mar 21. pii: S0748-7983(18)30954.
    PubMed     Text format     Abstract available


    February 2018
  14. ANGARITA FA, Acuna SA, McCready DR, Escallon J, et al
    Management of positive margins after initial lumpectomy in elderly women with breast cancer.
    Eur J Surg Oncol. 2018 Feb 21. pii: S0748-7983(18)30671.
    PubMed     Text format     Abstract available


  15. ALTUNDAG K
    Role of endocrine therapy in weak estrogen/progesterone receptor expression in HER2 negative breast cancer.
    Eur J Surg Oncol. 2018 Feb 6. pii: S0748-7983(18)30118.
    PubMed     Text format    


  16. DE LIGT KM, van Bommel ACM, Schreuder K, Maduro JH, et al
    The effect of being informed on receiving immediate breast reconstruction in breast cancer patients.
    Eur J Surg Oncol. 2018 Feb 2. pii: S0748-7983(18)30275.
    PubMed     Text format     Abstract available


  17. TASOULIS MK, Iqbal FM, Cawthorn S, MacNeill F, et al
    Reply to: Subcutaneous implant breast reconstruction: The importance of objectively assessing the outcomes.
    Eur J Surg Oncol. 2018;44:273.
    PubMed     Text format    


  18. ONESTI MG, Fanelli B, Di Taranto G
    Subcutaneous implant breast reconstruction: the importance of objectively assessing the outcomes.
    Eur J Surg Oncol. 2018;44:271-272.
    PubMed     Text format    


    January 2018
  19. LIAO GS
    Reply letter to: Role of endocrine therapy in weak estrogen/progesterone receptor expression in HER2 negative breast cancer.
    Eur J Surg Oncol. 2018 Jan 27. pii: S0748-7983(18)30117.
    PubMed     Text format    


  20. SASADA S, Masumoto N, Goda N, Kajitani K, et al
    Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study.
    Eur J Surg Oncol. 2018 Jan 17. pii: S0748-7983(18)30044.
    PubMed     Text format     Abstract available


  21. QIU SQ, Aarnink M, van Maaren MC, Dorrius MD, et al
    Validation and update of a lymph node metastasis prediction model for breast cancer.
    Eur J Surg Oncol. 2018 Jan 17. pii: S0748-7983(18)30037.
    PubMed     Text format     Abstract available


  22. ZHAO S, Ma D, Xiao Y, Jiang YZ, et al
    Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: A large population-based analysis.
    Eur J Surg Oncol. 2018 Jan 9. pii: S0748-7983(18)30002.
    PubMed     Text format     Abstract available


  23. RUBIO IT
    Variations in the opinion of breast surgeons and radiation oncologist regarding indications for radiation therapy after NSM: The need for prospective studies.
    Eur J Surg Oncol. 2018;44:3-4.
    PubMed     Text format    


  24. RECHT A
    Postmastectomy radiation therapy: What factors are important in recommending treatment to patients undergoing "Sparing" mastectomies.
    Eur J Surg Oncol. 2018;44:1-2.
    PubMed     Text format    


  25. JANSSEN NNY, van la Parra RFD, Loo CE, Groen EJ, et al
    Breast conserving surgery for extensive DCIS using multiple radioactive seeds.
    Eur J Surg Oncol. 2018;44:67-73.
    PubMed     Text format     Abstract available


  26. AHN SK, Han W, Moon HG, Kim MK, et al
    Management of benign papilloma without atypia diagnosed at ultrasound-guided core needle biopsy: Scoring system for predicting malignancy.
    Eur J Surg Oncol. 2018;44:53-58.
    PubMed     Text format     Abstract available


  27. NIINIKOSKI L, Hukkinen K, Leidenius MHK, Stahls A, et al
    Breast Lesion Excision System in the diagnosis and treatment of intraductal papillomas - A feasibility study.
    Eur J Surg Oncol. 2018;44:59-66.
    PubMed     Text format     Abstract available


    December 2017
  28. ONG JSL, Teh J, Saunders C, Bourke AG, et al
    Patient satisfaction with Radioguided Occult Lesion Localisation using iodine-125 seeds ('ROLLIS') versus conventional hookwire localisation.
    Eur J Surg Oncol. 2017;43:2261-2269.
    PubMed     Text format     Abstract available


    November 2017
  29. WESTENEND PJ, Storm R, Kock M, Kitzen J, et al
    The role of ultrasonography of the axilla and fine-needle aspiration cytology in breast cancer patients in the era of neo-adjuvant chemotherapy and axillary radiation; prevention of futile sentinel node procedures revisited.
    Eur J Surg Oncol. 2017 Nov 29. pii: S0748-7983(17)30979.
    PubMed     Text format    


  30. KRISCHER B, Forte S, Niemann T, Kubik-Huch RA, et al
    Feasibility of breast MRI after sentinel procedure for breast cancer with superparamagnetic tracers.
    Eur J Surg Oncol. 2017 Nov 26. pii: S0748-7983(17)30978.
    PubMed     Text format     Abstract available


  31. BUNDRED NJ
    Erratum to "Impact of Oncotype DX Breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK" [Eur J Surg Oncol 43 (5) (2017) 931-937].
    Eur J Surg Oncol. 2017 Nov 23. pii: S0748-7983(17)30539.
    PubMed     Text format    


  32. CHARALAMPOUDIS P, Markopoulos C, Kovacs T
    Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: A comprehensive review of current data.
    Eur J Surg Oncol. 2017 Nov 13. pii: S0748-7983(17)30955.
    PubMed     Text format     Abstract available


    August 2017
  33. MARTELLI G, Miceli R, Folli S, Guzzetti E, et al
    Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study.
    Eur J Surg Oncol. 2017 Aug 10. pii: S0748-7983(17)30607.
    PubMed     Text format     Abstract available


    July 2017
  34. LIAO GS, Dai MS, Hsu HM, Chu CH, et al
    Survival outcome of weak estrogen/progesterone receptor expression in HER2 negative breast cancer is similar to triple negative breast cancer.
    Eur J Surg Oncol. 2017 Jul 19. pii: S0748-7983(17)30585.
    PubMed     Text format     Abstract available


  35. THOMAS R, Pieri A, Cain H
    A systematic review of generic and breast cancer specific life expectancy models in the elderly.
    Eur J Surg Oncol. 2017 Jul 18. pii: S0748-7983(17)30575.
    PubMed     Text format     Abstract available


    May 2017
  36. CHARALAMPOUDIS P, Agrogiannis G, Kontzoglou K, Kouraklis G, et al
    Thyroid hormone receptor alpha (TRa) tissue expression in ductal invasive breast cancer: A study combining quantitative immunohistochemistry with digital slide image analysis.
    Eur J Surg Oncol. 2017 May 25. pii: S0748-7983(17)30495.
    PubMed     Text format     Abstract available


  37. HOUVENAEGHEL G, Boher JM, Michel V, Bannier M, et al
    Survival after breast cancer local recurrence according to therapeutic strategies.
    Eur J Surg Oncol. 2017 May 4. pii: S0748-7983(17)30448.
    PubMed     Text format     Abstract available


  38. TESHOME M, Kuerer HM
    Breast conserving surgery and locoregional control after neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2017;43:865-874.
    PubMed     Text format     Abstract available


  39. HOSSEINI A, Khoury AL, Esserman LJ
    Precision surgery and avoiding over-treatment.
    Eur J Surg Oncol. 2017;43:938-943.
    PubMed     Text format     Abstract available


    April 2017
  40. WIJGMAN DJ, Ten Wolde B, van Groesen NR, Keemers-Gels ME, et al
    Short term safety of oncoplastic breast conserving surgery for larger tumors.
    Eur J Surg Oncol. 2017;43:665-671.
    PubMed     Text format     Abstract available


  41. OJALA K, Meretoja TJ, Leidenius MH
    Aesthetic and functional outcome after breast conserving surgery - Comparison between conventional and oncoplastic resection.
    Eur J Surg Oncol. 2017;43:658-664.
    PubMed     Text format     Abstract available


    February 2017
  42. MEATTINI I, Francolini G, Livi L, Nori J, et al
    In reply to: Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer.
    Eur J Surg Oncol. 2017 Feb 21. pii: S0748-7983(17)30352.
    PubMed     Text format    


  43. ALTUNDAG K
    Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer.
    Eur J Surg Oncol. 2017 Feb 21. pii: S0748-7983(17)30353.
    PubMed     Text format    


  44. HAMELINCK VC, Stiggelbout AM, van de Velde CJ, Liefers GJ, et al
    Treatment recommendations for older women with breast cancer: A survey among surgical, radiation and medical oncologists.
    Eur J Surg Oncol. 2017 Feb 20. pii: S0748-7983(17)30351.
    PubMed     Text format     Abstract available


  45. KIDERLEN M, van de Velde CJ, Liefers GJ
    Targeted therapy in older women with breast cancer - What's the target?
    Eur J Surg Oncol. 2017 Feb 3. pii: S0748-7983(17)30109.
    PubMed     Text format     Abstract available


  46. MORGAN JL, Walters SJ, Collins K, Robinson TG, et al
    What influences healthcare professionals' treatment preferences for older women with operable breast cancer? An application of the discrete choice experiment.
    Eur J Surg Oncol. 2017 Feb 2. pii: S0748-7983(17)30107.
    PubMed     Text format     Abstract available


  47. PUKANCSIK D, Kelemen P, Ujhelyi M, Kovacs E, et al
    Objective decision making between conventional and oncoplastic breast-conserving surgery or mastectomy: An aesthetic and functional prospective cohort study.
    Eur J Surg Oncol. 2017;43:303-310.
    PubMed     Text format     Abstract available


    January 2017
  48. QIAN F, Qingping Y, Linquan W, Xiaojin H, et al
    High tumor-infiltrating FoxP3+ T cells predict poor survival in estrogen receptor-positive breast cancer: A meta-analysis.
    Eur J Surg Oncol. 2017 Jan 30. pii: S0748-7983(17)30062.
    PubMed     Text format     Abstract available


  49. SAVOLT A, Peley G, Polgar C, Udvarhelyi N, et al
    Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Eur J Surg Oncol. 2017 Jan 16. pii: S0748-7983(17)30038.
    PubMed     Text format     Abstract available


  50. LONCASTER J, Armstrong A, Howell S, Wilson G, et al
    Impact of Oncotype DX breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK.
    Eur J Surg Oncol. 2017 Jan 9. pii: S0748-7983(17)30037.
    PubMed     Text format     Abstract available


    December 2016
  51. CURTIT E, Mansi L, Maisonnette-Escot Y, Sautiere JL, et al
    Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX(R) Breast Recurrence Score Assay.
    Eur J Surg Oncol. 2016 Dec 14. pii: S0748-7983(16)31037.
    PubMed     Text format     Abstract available


  52. FONTEIN DB, Charehbili A, Nortier JW, Putter H, et al
    Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04).
    Eur J Surg Oncol. 2016 Dec 10. pii: S0748-7983(16)31011.
    PubMed     Text format     Abstract available


  53. ZHANG P, Li CZ, Jiao GM, Zhang JJ, et al
    Effects of ovarian ablation or suppression in premenopausal breast cancer: A meta-analysis of randomized controlled trials.
    Eur J Surg Oncol. 2016 Dec 5. pii: S0748-7983(16)31005.
    PubMed     Text format     Abstract available


    November 2016
  54. MEATTINI I, Bicchierai G, Saieva C, De Benedetto D, et al
    Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.
    Eur J Surg Oncol. 2016 Nov 17. pii: S0748-7983(16)30965.
    PubMed     Text format     Abstract available


    October 2016
  55. TEIXEIRA SC, Koolen BB, Elkhuizen PH, Vrancken Peeters MT, et al
    PET/CT with 18F-FDG predicts short-term outcome in stage II/III breast cancer patients upstaged to N2/3 nodal disease.
    Eur J Surg Oncol. 2016 Oct 31. pii: S0748-7983(16)30950.
    PubMed     Text format     Abstract available


  56. CRISCITIELLO C, Curigliano G, Burstein HJ, Wong S, et al
    Breast conservation following neoadjuvant therapy for breast cancer in the modern era: Are we losing the opportunity?
    Eur J Surg Oncol. 2016 Oct 29. pii: S0748-7983(16)30949.
    PubMed     Text format     Abstract available


  57. OMARINI C, Guaitoli G, Noventa S, Andreotti A, et al
    Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients.
    Eur J Surg Oncol. 2016 Oct 20. pii: S0748-7983(16)30940.
    PubMed     Text format     Abstract available


    August 2016
  58. JOHNS N, Dixon JM
    Should patients with early breast cancer still be offered the choice of breast conserving surgery or mastectomy?
    Eur J Surg Oncol. 2016 Aug 31. pii: S0748-7983(16)30861.
    PubMed     Text format     Abstract available


  59. NOS C, Clough KB, Bonnier P, Lasry S, et al
    Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection.
    Eur J Surg Oncol. 2016 Aug 26. pii: S0748-7983(16)30832.
    PubMed     Text format     Abstract available


    July 2016
  60. ZHANG P, Li CZ, Wu CT, Jiao GM, et al
    Comparison of immediate breast reconstruction after mastectomy and mastectomy alone for breast cancer: A meta-analysis.
    Eur J Surg Oncol. 2016 Jul 27. pii: S0748-7983(16)30673.
    PubMed     Text format     Abstract available


  61. UJHELYI M, Pukancsik D, Kelemen P, Kovacs E, et al
    Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases.
    Eur J Surg Oncol. 2016 Jul 9. pii: S0748-7983(16)30635.
    PubMed     Text format     Abstract available


    June 2016
  62. ZHANG Y, Mo M, Li JW, Zhou Y, et al
    Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.
    Eur J Surg Oncol. 2016 Jun 23. pii: S0748-7983(16)30588.
    PubMed     Text format     Abstract available


    May 2016
  63. GENNARI R, Griguolo G, Dieci MV, Guarneri V, et al
    Fat grafting for breast cancer patients: From basic science to clinical studies.
    Eur J Surg Oncol. 2016 May 27. pii: S0748-7983(16)30162.
    PubMed     Text format     Abstract available


  64. VERHEUVEL NC, Voogd AC, Tjan-Heijnen VC, Roumen RM, et al
    Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients.
    Eur J Surg Oncol. 2016 May 24. pii: S0748-7983(16)30157.
    PubMed     Text format     Abstract available


  65. BOCCARDO C, Gentilini O
    Contralateral risk reducing mastectomy in patients with sporadic breast cancer. Benefits and hazards.
    Eur J Surg Oncol. 2016 May 3. pii: S0748-7983(16)30115.
    PubMed     Text format     Abstract available


  66. OH DD, Flitcroft K, Brennan ME, Spillane AJ, et al
    Patterns and outcomes of breast reconstruction in older women - A systematic review of the literature.
    Eur J Surg Oncol. 2016;42:604-15.
    PubMed     Text format     Abstract available


  67. YIANNAKOPOULOU EC, Mathelin C
    Oncoplastic breast conserving surgery and oncological outcome: Systematic review.
    Eur J Surg Oncol. 2016;42:625-30.
    PubMed     Text format     Abstract available


  68. LUITEN EJ, Beek MA, Rubio IT
    Clinical utility of Axillary Reverse Mapping (ARM) in an era of changing perceptions concerning axillary surgery.
    Eur J Surg Oncol. 2016;42:585-7.
    PubMed     Text format    


  69. RUBIO IT, Ahmed M, Kovacs T, Marco V, et al
    Margins in breast conserving surgery: A practice-changing process.
    Eur J Surg Oncol. 2016;42:631-40.
    PubMed     Text format     Abstract available


    April 2016
  70. FATAYER H, Sharma N, Manuel D, Kim B, et al
    Serial MRI scans help in assessing early response to neoadjuvant chemotherapy and tailoring breast cancer treatment.
    Eur J Surg Oncol. 2016 Apr 20. pii: S0748-7983(16)30033.
    PubMed     Text format     Abstract available


  71. KIROVA YM
    Radiation therapy (RT) after breast-conserving surgery (BCS) in 2015--The year of radiation therapy advances.
    Eur J Surg Oncol. 2016;42:437-40.
    PubMed     Text format     Abstract available


    March 2016
  72. FUJIMOTO H, Ishikawa T, Satake T, Ko S, et al
    Donor site selection and clinical outcomes of nipple-areola skin-sparing mastectomy with immediate autologous free flap reconstruction: A single-institution experience.
    Eur J Surg Oncol. 2016;42:369-75.
    PubMed     Text format     Abstract available


    February 2016
  73. GHIGNONE F, van Leeuwen BL, Montroni I, Huisman MG, et al
    The assessment and management of older cancer patients: A SIOG surgical task force survey on surgeons' attitudes.
    Eur J Surg Oncol. 2016;42:297-302.
    PubMed     Text format     Abstract available


    January 2016
  74. APTE A, Walsh M, Chandrasekharan S, Chakravorty A, et al
    Single-stage immediate breast reconstruction with acellular dermal matrix: Experience gained and lessons learnt from patient reported outcome measures.
    Eur J Surg Oncol. 2016;42:39-44.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: